ABNORMAL HEMOGLOBINS, CATIONS, AND VOLUME IN RED CELLS

红细胞中的血红蛋白、阳离子和体积异常

基本信息

  • 批准号:
    3350686
  • 负责人:
  • 金额:
    $ 16.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1986
  • 资助国家:
    美国
  • 起止时间:
    1986-04-01 至 1989-03-31
  • 项目状态:
    已结题

项目摘要

The proposed research plan will focus on the relationship between mutations in the primary structure of hemoglobin and mechanisms regulating cation content and cell volume of human red cells. This proposal stems from our observation that CC cells (cells homozygous for hemoglobin C) possess a ouabain- bumetanide-resistant pathway for K transport that is pH and volume dependent and allows CC cells to regulate their volume upon swelling. The reduction of cation and water content described in CC cells takes place through this pathway. This suggests a possible role for the relatively positive charged hemoglobin C in the activation of a pathway involved in the control of cell volume. Specific aims include: 1) Further characterization of the pH and volume dependent K transport system of CC cells; 2) Testing the hypothesis that hemoglobin C is responsible for the activation of this pathway; 3) Investigation of cation transport properties of other relatively positive or negative charged hemoglobin variants; 4) Examination of the mechanisms involved in the control of cation and water content, and cell volume in cells homozygous (SS), and heterozygous (AS) for hemoglobin S, and SC cells, and their role in cell sickling. These studies should provide new information on the mechanism by which this pH and volume dependent pathway for K transport is activated in CC cells. In addition, these studies may also provide new insights into the role of hemoglobin-membrane interactions in the regulation of cation content and cell volume and possibly provide a new approach to the study of cation permeability changes induced by sickling.
拟议的研究计划将侧重于突变之间的关系

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Carlo Brugnara其他文献

Carlo Brugnara的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Carlo Brugnara', 18)}}的其他基金

Genetic Determinants of Erythrocyte Hydration
红细胞水合的遗传决定因素
  • 批准号:
    7104580
  • 财政年份:
    2006
  • 资助金额:
    $ 16.23万
  • 项目类别:
Genetic Determinants of Erythrocyte Hydration
红细胞水合的遗传决定因素
  • 批准号:
    7391161
  • 财政年份:
    2006
  • 资助金额:
    $ 16.23万
  • 项目类别:
Genetic Determinants of Erythrocyte Hydration
红细胞水合的遗传决定因素
  • 批准号:
    7590417
  • 财政年份:
    2006
  • 资助金额:
    $ 16.23万
  • 项目类别:
Genetic Determinants of Erythrocyte Hydration
红细胞水合的遗传决定因素
  • 批准号:
    7198074
  • 财政年份:
    2006
  • 资助金额:
    $ 16.23万
  • 项目类别:
EFFECT OF DIETARY MAGNESIUM ON RED CELL MAGNESIUM, VOLUME AND K/CL COTRANSPORT
膳食镁对红细胞镁、容量和 K/CL 协同转运的影响
  • 批准号:
    7204657
  • 财政年份:
    2005
  • 资助金额:
    $ 16.23万
  • 项目类别:
CELLULAR DETERMINANTS OF RED CELL SICKLING
红细胞镰状化的细胞决定因素
  • 批准号:
    6325889
  • 财政年份:
    2000
  • 资助金额:
    $ 16.23万
  • 项目类别:
CELLULAR DETERMINANTS OF RED CELL SICKLING
红细胞镰状化的细胞决定因素
  • 批准号:
    6109386
  • 财政年份:
    1999
  • 资助金额:
    $ 16.23万
  • 项目类别:
EFFECT OF DIETARY MAGNESIUM ON RED CELL MAGNESIUM, VOLUME AND K/CL COTRANSPORT
膳食镁对红细胞镁、容量和 K/CL 协同转运的影响
  • 批准号:
    6120793
  • 财政年份:
    1998
  • 资助金额:
    $ 16.23万
  • 项目类别:
CELLULAR DETERMINANTS OF RED CELL SICKLING
红细胞镰状化的细胞决定因素
  • 批准号:
    6272518
  • 财政年份:
    1998
  • 资助金额:
    $ 16.23万
  • 项目类别:
LONG TERM USE OF CLOTRIMAZOLE AS A THERAPEUTIC AGENT FOR SICKLE CELL DISEASE
长期使用克霉唑作为镰状细胞病的治疗剂
  • 批准号:
    6120784
  • 财政年份:
    1998
  • 资助金额:
    $ 16.23万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了